Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (91-100 of 271) with videos related to

Pageof 28
Sort By:
Open Forum Infectious Diseases|January 15, 2021
Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture RiskMona Abdo, Ryan P Coyle, Sharon M Seifert, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir RegimenAmie L Meditz, Claire Palmer, Julie Predhomme, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With MenMartin Hoenigl, Adiba Hassan, David J Moore, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 3, 2015
Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantificationLeah C Jimmerson, Michelle L Ray, Lane R Bushman, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-EmtricitabineXinhui Chen, Jose R Castillo-Mancilla, Sharon M Seifert, et al.
Plos One|November 11, 2016
Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside TriphosphatesXinhui Chen, Sharon M Seifert, Jose R Castillo-Mancilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detectionK Rivet Amico, Julia L Marcus, Vanessa McMahan, et al.
AIDS Research and Human Retroviruses|November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
AIDS and Behavior|May 30, 2024
A Pilot Randomized Controlled Trial of an mHealth Intervention to Improve PrEP Adherence Among Young Sexual Minority MenKeith J Horvath, Jonathan L Helm, Ashley Black, et al.
Clinical Pharmacology and Therapeutics|November 2, 2019
Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure ProphylaxisStephanie N Liu, Brandon T Gufford, Jessica Bo Li Lu, et al.
Pageof 28

Showing results (91-100 of 271) with videos related to

Sort By:
Pageof 28
Open Forum Infectious Diseases|January 15, 2021
Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture RiskMona Abdo, Ryan P Coyle, Sharon M Seifert, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir RegimenAmie L Meditz, Claire Palmer, Julie Predhomme, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With MenMartin Hoenigl, Adiba Hassan, David J Moore, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 3, 2015
Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantificationLeah C Jimmerson, Michelle L Ray, Lane R Bushman, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-EmtricitabineXinhui Chen, Jose R Castillo-Mancilla, Sharon M Seifert, et al.
Plos One|November 11, 2016
Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside TriphosphatesXinhui Chen, Sharon M Seifert, Jose R Castillo-Mancilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detectionK Rivet Amico, Julia L Marcus, Vanessa McMahan, et al.
AIDS Research and Human Retroviruses|November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure ProphylaxisMustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
AIDS and Behavior|May 30, 2024
A Pilot Randomized Controlled Trial of an mHealth Intervention to Improve PrEP Adherence Among Young Sexual Minority MenKeith J Horvath, Jonathan L Helm, Ashley Black, et al.
Clinical Pharmacology and Therapeutics|November 2, 2019
Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure ProphylaxisStephanie N Liu, Brandon T Gufford, Jessica Bo Li Lu, et al.
Pageof 28